Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Alaunos Therapeutics (TCRT)  
$0.17 0.00 (0.00%) as of 4:30 Wed 1/31


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 214,290,000
Market Cap: 36.13(M)
Last Volume: 2,552,505 Avg Vol: 2,452,798
52 Week Range: $0.0447 - $0.65
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NASDAQ COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Alaunos Therapeutics is an oncology-focused cell therapy company developing adoptive T-cell receptor (TCR) therapies, designed to treat various solid tumor types in cancer patient. Co. is utilizing its cancer mutation hotspot TCR library and its proprietary, non-viral Sleeping Beauty genetic engineering technology to design and manufacture patient-specific cell therapies that target neoantigens arising from tumor-related mutations in main oncogenic genes, including KRAS, TP53 and EGFR. Co. evaluates TCRs reactive to mutated KRAS, TP53 and EGFR from its TCR library for the investigational treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian and bile duct cancers.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 2,000,000
Total Buy Value $0 $0 $0 $1,300,000
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 2
Total Shares Sold 0 0 68,014 68,014
Total Sell Value $0 $0 $9,542 $9,542
Total People Sold 0 0 1 1
Total Sell Transactions 0 0 1 1
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 308
  Page 5 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Lafond Kevin G Vice Pres., Treasurer & CAO   •       –      –    2017-12-29 4 A $0.00 $0 D/D 53,000 110,967     -
   Fowler Wyche Director   –       •      –    2017-12-29 4 A $0.00 $0 D/D 17,258 163,328     -
   Belbel Caesar J COO, CLO, and Secretary   •       –      –    2017-12-29 4 A $0.00 $0 D/D 87,000 260,551     -
   Cooper Laurence James Neil Chief Executive Officer   •       –      –    2017-12-29 4 A $0.00 $0 D/D 348,000 1,431,731     -
   Weiser Michael Director   –       •      –    2017-12-29 4 A $0.00 $0 D/D 17,258 230,303     -
   Cannon James Anthony Director   –       •      –    2017-12-12 4 D $4.17 $54,602 D/D (13,094) 374,408     -
   Cannon James Anthony Director   –       •      –    2017-12-12 4 OE $2.73 $54,600 D/D 20,000 387,502     -
   Fowler Wyche Director   –       •      –    2017-12-11 4 D $4.20 $66,360 D/D (15,800) 146,070     -
   Fowler Wyche Director   –       •      –    2017-12-11 4 OE $2.73 $54,600 D/D 20,000 161,870     -
   Weiser Michael Director   –       •      –    2017-12-08 4 D $4.43 $54,600 D/D (12,325) 213,045     -
   Weiser Michael Director   –       •      –    2017-12-08 4 OE $2.73 $54,600 D/D 20,000 225,370     -
   Brennan Murray Director   –       •      –    2017-11-20 4 D $4.32 $54,600 D/D (12,639) 62,175     -
   Brennan Murray Director   –       •      –    2017-11-20 4 OE $2.73 $54,600 D/D 20,000 74,814     -
   Cooper Laurence James Neil Chief Executive Officer   •       –      –    2017-11-08 4 B $4.68 $30,139 D/D 6,440 1,083,731 2.74     -
   Mauney David M Md EVP and Chief Business Officer   •       –      –    2017-11-08 4 B $4.68 $19,984 D/D 4,270 58,662 2.74     -
   Cannon James Anthony Director   –       •      –    2017-06-12 4 OE $4.85 $72,750 D/D 15,000 367,502     -
   Brennan Murray Director   –       •      –    2017-06-12 4 D $5.47 $72,751 D/D (13,300) 54,814     -
   Brennan Murray Director   –       •      –    2017-06-12 4 OE $4.85 $72,750 D/D 15,000 68,114     -
   Fowler Wyche Director   –       •      –    2017-06-12 4 D $5.47 $76,471 D/D (13,980) 141,870     -
   Fowler Wyche Director   –       •      –    2017-06-12 4 OE $4.85 $72,750 D/D 15,000 155,850     -
   Weiser Michael Director   –       •      –    2017-06-12 4 D $5.47 $72,751 D/D (13,300) 205,370     -
   Weiser Michael Director   –       •      –    2017-06-12 4 OE $4.85 $72,750 D/D 15,000 218,670     -
   Belbel Caesar J COO, CLO, and Secretary   •       –      –    2017-06-01 4 D $6.11 $101,829 D/D (16,666) 173,551     -
   Cooper Laurence James Neil Chief Executive Officer   •       –      –    2017-05-05 4 D $7.12 $939,840 D/D (132,000) 1,077,291     -
   Brennan Murray Director   –       •      –    2016-12-31 4 D $5.35 $56,485 D/D (10,558) 53,114     -

  308 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed